Decoding tau acetylation in Alzheimer’s disease and tauopathies: from site-specific mechanisms to therapeutic horizons
Tau acetylation has been recognized as a pivotal post-translational modification associated with the pathogenesis of Alzheimer’s disease (AD) and other tauopathies. This review offers a detailed synthesis of the current understanding of site-specific tau acetylation, its regulatory enzymes, and its...
Uložené v:
| Vydané v: | BMB reports Ročník 58; číslo 8; s. 325 - 339 |
|---|---|
| Hlavní autori: | , |
| Médium: | Journal Article |
| Jazyk: | Korean |
| Vydavateľské údaje: |
생화학분자생물학회
31.08.2025
|
| Predmet: | |
| ISSN: | 1976-6696, 1976-670X |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Tau acetylation has been recognized as a pivotal post-translational modification associated with the pathogenesis of Alzheimer’s disease (AD) and other tauopathies. This review offers a detailed synthesis of the current understanding of site-specific tau acetylation, its regulatory enzymes, and its profound impacts on tau biology. Acetylation influences tau degradation, aggregation, propagation, and microtubule-binding properties in a residue-specific manner, often in conjunction with other modifications such as phosphorylation and ubiquitination. Furthermore, this review emphasizes emerging therapeutic strategies targeting tau acetylation, including small-molecule inhibitors of p300/CBP and monoclonal antibodies against acetylated tau epitopes. While several of these approaches are currently undergoing clinical trials, many acetylation sites are still inadequately characterized, emphasizing the need for additional mechanistic studies. An enhanced understanding of tau acetylation will be vital for devising targeted therapies to halt or reverse the progression of tau-mediated neurodegeneration. [BMB Reports 2025; 58(8): 325-339] |
|---|---|
| AbstractList | Tau acetylation has been recognized as a pivotal post-translational modification associated with the pathogenesis of Alzheimer's disease (AD) and other tauopathies. This review offers a detailed synthesis of the current understanding of site-specific tau acetylation, its regulatory enzymes, and its profound impacts on tau biology. Acetylation influences tau degradation, aggregation, propagation, and microtubule-binding properties in a residue-specific manner, often in conjunction with other modifications such as phosphorylation and ubiquitination. Furthermore, this review emphasizes emerging therapeutic strategies targeting tau acetylation, including small-molecule inhibitors of p300/CBP and monoclonal antibodies against acetylated tau epitopes. While several of these approaches are currently undergoing clinical trials, many acetylation sites are still inadequately characterized, emphasizing the need for additional mechanistic studies. An enhanced understanding of tau acetylation will be vital for devising targeted therapies to halt or reverse the progression of tau-mediated neurodegeneration. Tau acetylation has been recognized as a pivotal post-translational modification associated with the pathogenesis of Alzheimer’s disease (AD) and other tauopathies. This review offers a detailed synthesis of the current understanding of site-specific tau acetylation, its regulatory enzymes, and its profound impacts on tau biology. Acetylation influences tau degradation, aggregation, propagation, and microtubule-binding properties in a residue-specific manner, often in conjunction with other modifications such as phosphorylation and ubiquitination. Furthermore, this review emphasizes emerging therapeutic strategies targeting tau acetylation, including small-molecule inhibitors of p300/CBP and monoclonal antibodies against acetylated tau epitopes. While several of these approaches are currently undergoing clinical trials, many acetylation sites are still inadequately characterized, emphasizing the need for additional mechanistic studies. An enhanced understanding of tau acetylation will be vital for devising targeted therapies to halt or reverse the progression of tau-mediated neurodegeneration. [BMB Reports 2025; 58(8): 325-339] |
| Author | Yoonah R. Oh Min-kyoo Shin |
| Author_xml | – sequence: 2 fullname: Yoonah R. Oh – sequence: 3 – sequence: 4 fullname: Min-kyoo Shin |
| BookMark | eNo9kL1OwzAcxC1UJErpjsTihTHFsRM7Zmv5hqJKqANb5Nr_EKuNHcWuRDvxGrweT0IrPpa7k-6nG-4Y9Zx3gNBpSkZ5VrCLyfPkBdoRJTRPCBHiAPVTKXjCBXnt_WUu-REahmAXJMsES4UkffR-Ddob695wVGusNMTNSkXrHbYOj1fbGmwD3dfHZ8DGBlABsHJmD_tWxdpCuMRV5xscbIQktKBtZTVuQNfK2dAEHD2ONXSqhXXcNbXv7Na7cIIOK7UKMPz1AZrf3syv7pPp7O7hajxNljmRCTWF4ELmIAyR3GRgFsVOOcu1YFxQAmB4bghNC8k1F4zqQlckNyYz2rCKDdD5z-zShmhLZ8KqfBw_zfZXUc55SjkjudxxZ_9cKNvONqrblFkqSUYy9g3WPmzL |
| ContentType | Journal Article |
| DBID | HZB Q5X JDI |
| DEWEY | 572 |
| DOI | 10.5483/BMBRep.2025-0077 |
| DatabaseName | Korean Studies Information Service System (KISS) Korean Studies Information Service System (KISS) B-Type [Open Access] KoreaScience |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Chemistry Anatomy & Physiology |
| DocumentTitleAlternate | Decoding tau acetylation in Alzheimer’s disease and tauopathies: from site-specific mechanisms to therapeutic horizons |
| EISSN | 1976-670X |
| EndPage | 339 |
| ExternalDocumentID | JAKO202526661263059 4190404 |
| GroupedDBID | --- 23N 2WC 5GY 5VS 85H 87B 9ZL AAFWJ ACGFO ACYCR ADBBV AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV DIK E3Z F5P GROUPED_DOAJ GX1 HH5 HYE HZB JDI KQ8 OVT Q5X RNS RPM TR2 53G IPNFZ RIG |
| ID | FETCH-LOGICAL-k509-2d876795e7d096d4edb8d4e635c736720eed65d021896c6732c8cf05dd4dcd3f3 |
| ISSN | 1976-6696 |
| IngestDate | Wed Oct 08 04:37:49 EDT 2025 Tue Oct 14 02:10:44 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 8 |
| Keywords | Tauopathies Tau Acetylation Alzheimer's disease |
| Language | Korean |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-k509-2d876795e7d096d4edb8d4e635c736720eed65d021896c6732c8cf05dd4dcd3f3 |
| Notes | Korean Society for Biochemistry and Molecular Biology KISTI1.1003/JNL.JAKO202526661263059 |
| OpenAccessLink | http://click.ndsl.kr/servlet/LinkingDetailView?cn=JAKO202526661263059&dbt=JAKO&org_code=O481&site_code=SS1481&service_code=01 |
| PageCount | 15 |
| ParticipantIDs | kisti_ndsl_JAKO202526661263059 kiss_primary_4190404 |
| PublicationCentury | 2000 |
| PublicationDate | 20250831 |
| PublicationDateYYYYMMDD | 2025-08-31 |
| PublicationDate_xml | – month: 08 year: 2025 text: 20250831 day: 31 |
| PublicationDecade | 2020 |
| PublicationTitle | BMB reports |
| PublicationTitleAlternate | BMB Reports |
| PublicationYear | 2025 |
| Publisher | 생화학분자생물학회 |
| Publisher_xml | – name: 생화학분자생물학회 |
| SSID | ssib044731790 ssj0061272 ssib053376789 |
| Score | 2.4302206 |
| Snippet | Tau acetylation has been recognized as a pivotal post-translational modification associated with the pathogenesis of Alzheimer’s disease (AD) and other... Tau acetylation has been recognized as a pivotal post-translational modification associated with the pathogenesis of Alzheimer's disease (AD) and other... |
| SourceID | kisti kiss |
| SourceType | Open Access Repository Publisher |
| StartPage | 325 |
| SubjectTerms | Acetylation Alzheimer’s disease Tau Tauopathies |
| Title | Decoding tau acetylation in Alzheimer’s disease and tauopathies: from site-specific mechanisms to therapeutic horizons |
| URI | https://kiss.kstudy.com/ExternalLink/Ar?key=4190404 http://click.ndsl.kr/servlet/LinkingDetailView?cn=JAKO202526661263059&dbt=JAKO&org_code=O481&site_code=SS1481&service_code=01 |
| Volume | 58 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1976-670X dateEnd: 99991231 omitProxy: false ssIdentifier: ssib044731790 issn: 1976-6696 databaseCode: M~E dateStart: 20080101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbKQIKXCVYQ4zL5AfESZaSxY8e8lTGEmLYh6EPfqsR21GhtMjXp1E4a4m_w9_glHDuXZhUS8MCLVVlN5eZ8Ouc7PjeEXoVaghEhzFWaJC4NwEEJhVauSiKfBTJOIhHbYRP87Cwcj8XnXu-mqYW5mvEsC1crcflfRQ17IGxTOvsP4m5_FDbgMwgdVhA7rH8l-PfgUNpKlTJaOpHU5bpKd7M3G7PrqU7NwJQ6x0EUTYimSqWMlrmdUVxlytnaExNedk1BpkkqcubalAqnxbyoWWtTveVM80V63Vz-tWHid01UYqNegPtPnS-Hznl7E32aZu7JOs-dr9O6EXh9D-EHzcVqqzqB2LiMibqxdWePe-Ouvg3CDq7CjvIkVQl0bYdJ1eRoW8WDh2VaTcD5wUM5rA7i1ZNgbnXT3rJybe7hp-HJuXkMmAmwOwb6TtxBd30eCKMUT78dN-qIUk4GnW6MQIw5s835K0MPT9vZYO0fr6Lg5oBvto8HBh_8gQI8IOMWpB0KM3qIdmvfAw8rzDxCvYt8D_WHWVTm8zV-jW02sA2z7KH7R80kwD5aNZDCgA_cgRROM9xC6uf3HwWuwYQBTLgDprfYQAnfghLeQAmXOe5ACTdQeoxGH45HRx_demKHexGYSJ0C28pFoLkCz1hRreIQVuC0khPGfQ8IGQuUoZWCScaJL0OZeIFSVElFEvIE7WR5pp8irPSAeZEQ2pMxJSyJWAJuIPWIimOa-IN91DcvdHJZ9WSZUCC21KP76MC-4EmmitnkN6J-9qcvPEcPNuh-gXbKxVK_RPfkVZkWiwMLkF_IGYND |
| linkProvider | ISSN International Centre |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Decoding+tau+acetylation+in+Alzheimer%E2%80%99s+disease+and+tauopathies%3A+from+site-specific+mechanisms+to+therapeutic+horizons&rft.jtitle=BMB+reports&rft.au=Yoonah+R.+Oh&rft.au=Min-Kyoo+Shin&rft.date=2025-08-31&rft.issn=1976-6696&rft.eissn=1976-670X&rft.volume=58&rft.issue=8&rft.spage=325&rft.epage=339&rft_id=info:doi/10.5483%2FBMBRep.2025-0077&rft.externalDBID=n%2Fa&rft.externalDocID=JAKO202526661263059 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1976-6696&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1976-6696&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1976-6696&client=summon |